Blonanserin T1180
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Blonanserin is an atypical antipsychotic approved in Japan in January, 2008. Relative to many other antipsychotics, blonanserin has an improved tolerability profile, lacking side effects such as extrapyramidal symptoms, excessive sedation, or hypotension.
CAS nr:
132810-10-7
Purity:
98%
Molecular Weight:
367,5
SMILES:
CCN1CCN(CC1)c1nc2c(CCCCCC2)c(c1)c1ccc(F)cc1
Formula:
C23H30FN3
Pathway:
GPCR/G Protein,GPCR/G Protein,Neuroscience,GPCR/G Protein,Neuroscience,Neuroscience,GPCR/G Protein
Target:
Sigma receptor,5-HT Receptor,5-HT Receptor,Dopamine Receptor,Dopamine Receptor,Adrenergic Receptor,Adrenergic Receptor
